Arkolith/Insider Trading/INDV/Form 4

Anderson Woodrow D

Chief Accounting OfficerIndivior Pharmaceuticals, Inc. (INDV) · full profile →Form 4 · filed Mar 5, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2026Tax withholding(F)8K$31.98$265K21K
Mar 3, 2026Option exercise(M)6K——27K
Mar 3, 2026Tax withholding(F)3K$31.98$86K25K
Mar 3, 2026Option exercise(M)18K——30K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 3, 2026Option exercise(M)24K——0
Mar 3, 2026Option exercise(M)6K——0

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002014440-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML